1–2 Days Delivery in US
1–2 Days Delivery in US
The Breakthrough Treatment for Hypertrophic Cardiomyopathy (HCM) in Cats
Petvital® Rapamycin (Sirolimus) Delayed-release Tablets for Cats
Rapamycin (Sirolimus) is a newly FDA conditionally approved for hypertrophic cardiomyopathy (HCM) in cats. By slowing the progression of heart changes, Rapamycin (Sirolimus) brings hope to cats suffering from HCM.
Rapamycin (Sirolimus) — Targeted HCM Therapy
Clinical studies show Rapamycin reduces pathological left ventricular thickening and supports cardiac function in cats with hypertrophic cardiomyopathy (HCM).
Stops HCM progression
Reduces abnormal left ventricular thickening and slows mid-stage progression.
Stops HCM progression
Reduces abnormal left ventricular thickening and slows mid-stage progression.
Stops HCM progression
Reduces abnormal left ventricular thickening and slows mid-stage progression.
About PetVital
Factory-Direct Pet Care
PetVital is a factory-direct supplier for pet owners, dedicated to providing high-quality and affordable pet medications. With 50 years of experience in animal pharmaceutical production and operations, we partner with more than 60 leading European brands and operate GMP-certified production facilities compliant with EU standards. Through our factory-direct model, we reduce unnecessary costs and make sure every pet in need can receive timely treatment.
50+
Years of experience
60+
European brand partners
16+
Research Institutes
Factory-Direct
Lower cost & timely care
Petvital® Rapamycin (Sirolimus) Delayed-release
Tablets for Cats * for subclinical HCM
Petvital® Mavacamten Tablets for Cats
* for Acute Heart Failure Stage HCM
Results Of The RAPACAT Trial
How Rapamycin Was Proven Effective in Cats with HCM
- Over a 6-month follow-up, untreated cats with subclinical HCM developed significant thickening of the left ventricle.
- Cats with higher levels of NTproBNP, a blood marker of heart disease, showed faster progression of this thickening.
- Intermittent inhibition of mTOR with rapamycin successfully prevented the progression of left ventricular hypertrophy.